Internet- und mobilbasierte Interventionen wie beispielsweise Online-Selbsthilfeprogramme oder Rückfall-Früherkennungs-Systeme mittels Textnachrichten können das Behandlungsangebot für von Schizophrenie Betroffene auf vielfältige Art und Weise erweitern. So können evidenzbasierte Ansätze wie die kognitive Verhaltenstherapie für Schizophrenie, die bisher aufgrund des Versorgungsdefizits vielen Betroffenen nicht zur Verfügung stehen, als Internet-basierte Selbsthilfeprogramme disseminiert werden. Auch pharmakologische Behandlungen können mit technischen Hilfsmitteln unterstützt werden. Chancen und Risiken dieser Interventionen werden aus Sicht von Behandelnden und Betroffenen auf der Grundlage bisher publizierter Studien diskutiert. Der Zugang zu und die Bedienung von Computern oder Smartphones stellt vielen empirischen Untersuchungen zufolge für die meisten Menschen mit Schizophrenie keine Barriere dar. Auch wenn sich die Wirksamkeit von Internet- und mobilbasierten Ansätzen für Schizophrenie im Moment noch nicht abschließend beurteilen lässt, ist zu erwarten, dass die neuen Entwicklungen auf diesem Feld für Betroffene eine größere Auswahl an Behandlungsangeboten hervorbringen wird, zwischen denen sie je nach Lebenssituation und Bedürfnissen wählen können.

Keywords:
Selbsthilfe, Internet-Therapie, Schizophrenie, Psychose, eHealth
1.
Alvarez-Jimenez M, Bendall S, Lederman R, Wadley G, Chinnery G, Vargas S, et al: On the HORYZON: moderated online social therapy for long-term recovery in first episode psychosis. Schizophr Res 2013;143:143-149.
2.
Álvarez-Jiménez M, Gleeson J F, Bendall S, Lederman R, Wadley G, Killackey E, McGorry PD: Internet-based interventions for psychosis. Psychiatr Clin North Am 2012;35:735-747.
3.
Andersson G: Internet-delivered psychological treatments. Annu Rev Clin Psychol 2016;12:157-179.
4.
Andersson G, Cuijpers P, Carlbring P, Riper H, Hedman E: Guided Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta-analysis. World Psychiatry 2014;13:288-295.
5.
Baumeister H, Reichler L, Munzinger M, Lin J: The impact of guidance on Internet-based mental health interventions - a systematic review. Internet Interv 2014;1:205-215.
6.
Bechdolf A, Klingberg S: Psychotherapie bei schizophrenen Störungen: Kein Evidenz-, sondern ein Implementierungsproblem. Psychiatr Prax 2014;41:8-10.
7.
Ben-Zeev D, Brenner CJ, Begale M, Duffecy J, Mohr DC, Mueser KT: Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia. Schizophr Bull 2014;40:1244-1253.
8.
Ben-Zeev D, Davis KE, Kaiser S, Krzsos I, Drake RE: Mobile technologies among people with serious mental illness: opportunities for future services. Adm Policy Ment Health 2013;40:340-343.
9.
Berger T, Caspar F, Richardson R, Kneubühler B, Sutter D, Andersson G: Internet-based treatment of social phobia: a randomized controlled trial comparing unguided with two types of guided self-help. Behav Res Ther 2011;49:158-169.
10.
Biagianti B, Schlosser D, Nahum M, Woolley J, Vinogradov S: Creating Live Interactions to Mitigate Barriers (CLIMB): a mobile intervention to improve social functioning in people with chronic psychotic disorders. JMIR Ment Health 2016;3:e52.
11.
Bucci S, Barrowclough C, Ainsworth J, Morris R, Berry K, Machin M, et al: Using mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): study protocol for a randomised controlled trial. Trials 2015;16:404.
12.
Daker-White G, Rogers A: What is the potential for social networks and support to enhance future telehealth interventions for people with a diagnosis of schizophrenia: a critical interpretive synthesis. BMC Psychiatry 2013;13:279.
13.
Dear BF, Staples LG, Terides MD, Karin E, Zou J, Johnston L, et al: Transdiagnostic versus disorder-specific and clinician-guided versus self-guided internet-delivered treatment for generalized anxiety disorder and comorbid disorders: a randomized controlled trial. J Anxiety Disord 2015;36:63-77.
14.
Depp CA, Mausbach B, Granholm E, Cardenas V, Ben-Zeev D, Patterson TL, et al: Mobile interventions for severe mental illness. J Nerv Ment Dis 2010;198:715-721.
15.
DGPPN (Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde): S3-Behandlungsleitlinie Schizophrenie. Darmstadt, Steinkopff Verlag, 2005.
16.
Forchuk C, Donelle L, Ethridge P, Warner L: Client Perceptions of the Mental Health Engagement Network: a secondary analysis of an intervention using smartphones and desktop devices for individuals experiencing mood or psychotic disorders in Canada. JMIR Ment Health 2015;2:e1.
17.
Gaebel W, Großimlinghaus I, Kerst A, Cohen Y, Hinsche-Böckenholt A, Johnson B, et al: European Psychiatric Association (EPA) guidance on the quality of eMental health interventions in the treatment of psychotic disorders. Eur Arch Psychiatry Clin Neurosci 2016;266:125-137.
18.
Gay K, Torous J, Joseph A, Pandya A, Duckworth K: Digital technology use among individuals with schizophrenia: results of an online survey. JMIR Ment Health 2016;3:e15.
19.
Gleeson J, Lederman R, Herrman H, Koval P, Eleftheriadis D, Bendall S, et al: Moderated online social therapy for carers of young people recovering from first-episode psychosis: study protocol for a randomised controlled trial. Trials 2017;18:27.
20.
Gottlieb JD, Romeo KH, Penn DL, Mueser KT, Chiko BP: Web-based cognitive-behavioral therapy for auditory hallucinations in persons with psychosis: a pilot study. Schizophr Res 2013;145:82-87.
21.
Granholm E, Ben-Zeev D, Link PC, Bradshaw KR, Holden JL: Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations. Schizophr Bull 2012;38:414-425.
22.
Highton-Williamson E, Priebe S, Giacco D: Online social networking in people with psychosis: a systematic review. Int J Soc Psychiatry 2015;61:92-101.
23.
Husain N, Gire N, Kelly J, Duxbury J, McKeown M, Riley M, et al: TechCare: mobile assessment and therapy for psychosis - an intervention for clients in the Early Intervention Service: a feasibility study protocol. SAGE Open Med 2016;4:2050312116669613.
24.
Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR: Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry 2014;204:20-29.
25.
Jones RB, Atkinson JM, Coia DA, Paterson L, Morton AR, McKenna K, et al: Randomised trial of personalised computer based information for patients with schizophrenia. BMJ 2001;322:835.
26.
Komatsu H, Sekine Y, Okamura N, Kanahara N, Okita K, Matsubara S, et al: Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: a randomized controlled trial. Schizophr Res 2013;150:240-244.
27.
Leff J, Williams G, Huckvale MA, Arbuthnot M, Leff AP: Computer-assisted therapy for medication-resistant auditory hallucinations: proof-of-concept study. Br J Psychiatry 2013;202:428-433.
28.
Lincoln TM, Ziegler M, Mehl S, Kesting M-L, Lüllmann E, Westermann S, Rief W: Moving from efficacy to effectiveness in cognitive behavioral therapy for psychosis: a randomized clinical practice trial. J Consult Clin Psychol 2012;80:674-686.
29.
Lüllmann E, Lincoln TM: The effect of an educating versus normalizing approach on treatment motivation in patients presenting with delusions: an experimental investigation with analogue patients. Schizophr Res Treat 2013;2013:261587.
30.
Montes JM, Medina E, Gomez-Beneyto M, Maurino J: A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia. Psychiatry Res 2012;200:89-95.
31.
Moritz S, Berna F, Jaeger S, Westermann S, Nagel M: The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis. Eur Arch Psychiatry Clin Neurosci 2017;267:335-389.
32.
Moritz S, Favrod J, Andreou C, Morrison AP, Bohn F, Veckenstedt R, et al: Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis. Schizophr Bull 2013;39:917-922.
33.
Moritz S, Schröder J, Klein JP, Lincoln TM, Andreou C, Fischer A, Arlt S: Effects of online intervention for depression on mood and positive symptoms in schizophrenia. Schizophr Res 2016;175:216-222.
34.
Myin-Germeys I, Klippel A, Steinhart H, Reininghaus U: Ecological momentary interventions in psychiatry. Curr Opin Psychiatry 2016;29:1.
35.
Naeem F, Johal R, McKenna C, Rathod S, Ayub M, Lecomte T, et al: Cognitive Behavior Therapy for psychosis based Guided Self-help (CBTp-GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophr Res 2016;173:69-74.
36.
Naeem F, Munshi T, Xiang S, Yang M, Shokraneh F, Syed Y, et al: A survey of eMedia-delivered interventions for schizophrenia used in randomized controlled trials. Neuropsychiatr Dis Treat 2017;13:233-243.
37.
NICE (National Institute of Clinical Excellence): Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update). London, NICE, 2002.
38.
Oh H, DeVylder J: Possibilities and challenges of online, social media, and mobile technologies for psychosis treatment. Schizophr Res 2015;166:347-348.
39.
O'Hanlon P, Aref-Adib G, Fonseca A, Lloyd-Evans B, Osborn D, Johnson S: Tomorrow's world: current developments in the therapeutic use of technology for psychosis. BJPsych Adv 2016;22:301-310.
40.
Pijnenborg GHM, Withaar FK, Brouwer WH, Timmerman ME, van den Bosch RJ, Evans JJ: The efficacy of SMS text messages to compensate for the effects of cognitive impairments in schizophrenia. Br J Clin Psychol 2010;49:259-274.
41.
Richards D, Richardson T: Computer-based psychological treatments for depression: a systematic review and meta-analysis. Clin Psychol Rev 2012;32:329-342.
42.
Rotondi A, Haas G, Anderson C, Newhill C, Spring M, Ganguli R, et al: A clinical trial to test the feasibility of a telehealth psychoeducational intervention for persons with schizophrenia and their families: intervention and 3-month findings. Rehabil Psychol 2005;50:325-336.
43.
Rotondi AJ, Anderson CM, Haas GL, Eack SM, Spring MB, Ganguli R, et al: Web-based psychoeducational intervention for persons with schizophrenia and their supporters: one-year outcomes. Psychiatr Serv 2010;61:1099-1105.
44.
Rotondi AJ, Eack SM, Hanusa BH, Spring MB, Haas GL: Critical design elements of e-health applications for users with severe mental illness: singular focus, simple architecture, prominent contents, explicit navigation, and inclusive hyperlinks. Schizophr Bull 2015;41:440-448.
45.
Schröder J, Berger T, Meyer B, Lutz W, Hautzinger M, Späth C, et al: Attitudes towards internet interventions among psychotherapists and study participants with mild to moderate depression symptoms. Cogn Ther Res; in press. DOI: 10.1007/s10608-017-9850-0.
46.
Schröder J, Berger T, Westermann S, Klein JP, Moritz S: Internet interventions for depression: new developments. Dialogues Clin Neurosci 2016;18:203-212.
47.
Scott AJ, Webb TL, Rowse G: Self-help interventions for psychosis: a meta-analysis. Clin Psychol Rev 2015;39:96-112.
48.
Španiel F, Hrdlička J, Novák T, Kožený J, Höschl C, Mohr P, Motlová LB: Effectiveness of the Information Technology-Aided Program of Relapse Prevention in Schizophrenia (ITAREPS). J Psychiatr Pract 2012;18:269-280.
49.
Španiel F, Vohlídka P, Hrdlicka J, Kozený J, Novák T, Motlová L, et al: ITAREPS: information technology aided relapse prevention programme in schizophrenia. Schizophr Res 2008a;98:312-317.
50.
Španiel F, Vohlídka P, Kožený J, Novák T, Hrdlicka J, Motlová L, el al: The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up. Int J Clin Pract 2008b;62:1943-1946.
51.
Spek V, Cuijpers P, Nyklicek I, Riper H, Keyzer J, Pop V: Internet-based cognitive-behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med 2007;37:319-328.
52.
Steinwachs DM, Roter DL, Skinner EA, Lehman AF, Fahey M, Cullen B, et al: A Web-based program to empower patients who have schizophrenia to discuss quality of care with mental health providers. Psychiatr Serv 2011;62:1296-1302.
53.
Thomas N, Farhall J, Foley F, Rossell SL, Castle D, Ladd E, et al: Randomised controlled trial of a digitally assisted low intensity intervention to promote personal recovery in persisting psychosis: SMART-Therapy study protocol. BMC Psychiatry 2016;16:312.
54.
Turner DT, van der Gaag M, Karyotaki E, Cuijpers P: Psychological interventions for psychosis: a meta-analysis of comparative outcome studies. Am J Psychiatry 2014;31:697-704.
55.
Välimäki M, Athanasopoulou C, Lahti M, Adams CE: Effectiveness of social media interventions for people with schizophrenia: a systematic review and meta-analysis. J Med Internet Res 2016;18:e92.
56.
van der Krieke L, Wunderink L, Emerencia AC, de Jonge P, Sytema S: E-Mental health self-management for psychotic disorders: state of the art and future perspectives. Psychiatr Serv 2014;65:33-49.
57.
Velligan D, Mintz J, Maples N, Li X, Gajewski S, Carr H, Sierra C: A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophrenia. Schizophr Bull 2013;39:999-1007.
58.
Westermann S, Cavelti M, Heibach E, Caspar F: Motive-oriented therapeutic relationship building for patients diagnosed with schizophrenia. Front Psychol 2015;6:1294.
© 2017 S. Karger GmbH, Freiburg
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.